These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11755267)

  • 1. Biotinylated methotrexate loaded erythrocytes for enhanced liver uptake. 'A study on the rat'.
    Mishra PR; Jain NK
    Int J Pharm; 2002 Jan; 231(2):145-53. PubMed ID: 11755267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast lysis by complement and uptake by liver of avidin-carrying biotinylated erythrocytes.
    Muzykantov VR; Seregina N; Smirnov MD
    Int J Artif Organs; 1992 Oct; 15(10):622-7. PubMed ID: 1428212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface modified methotrexate loaded erythrocytes for enhanced macrophage uptake.
    Mishra PR; Jain NK
    J Drug Target; 2000; 8(4):217-24. PubMed ID: 11144232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
    Hoya K; Guterman LR; Miskolczi L; Hopkins LN
    Drug Deliv; 2001; 8(4):215-22. PubMed ID: 11757779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin.
    Muzykantov VR; Murciano JC; Taylor RP; Atochina EN; Herraez A
    Anal Biochem; 1996 Oct; 241(1):109-19. PubMed ID: 8921172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target-sensitive immunoerythrocytes: interaction of biotinylated red blood cells with immobilized avidin induces their lysis by complement.
    Muzykantov VR; Zaltsman AB; Smirnov MD; Samokhin GP; Morgan BP
    Biochim Biophys Acta; 1996 Mar; 1279(2):137-43. PubMed ID: 8603079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.
    Zaltzman AB; Van den Berg CW; Muzykantov VR; Morgan BP
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):651-6. PubMed ID: 7537958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avidin-induced lysis of biotinylated erythrocytes by homologous complement via the alternative pathway depends on avidin's ability of multipoint binding with biotinylated membrane.
    Muzykantov VR; Smirnov MD; Samokhin GP
    Biochim Biophys Acta; 1992 Jun; 1107(1):119-25. PubMed ID: 1616915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers.
    Yuan SH; Ge WH; Huo J; Wang XH
    Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth of human malaria parasites in biotinylated erythrocytes.
    Simpson GL; Born JL; Cain G
    Mol Biochem Parasitol; 1981 Dec; 4(5-6):243-53. PubMed ID: 7038477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avidin attachment to red blood cells via a phospholipid derivative of biotin provides complement-resistant immunoerythrocytes.
    Muzykantov VR; Smirnov MD; Klibanov AL
    J Immunol Methods; 1993 Feb; 158(2):183-90. PubMed ID: 8429223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
    Han JH; Oh YK; Kim DS; Kim CK
    Int J Pharm; 1999 Oct; 188(1):39-47. PubMed ID: 10528081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotinylation of human C3.
    Berger M; Gaither TA; Cole RM; Chused TM; Hammer CH; Frank MM
    Mol Immunol; 1982 Jul; 19(7):857-64. PubMed ID: 7121468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tannin-mediated attachment of avidin provides complement-resistant immunoerythrocytes that can be lysed in the presence of activator of complement.
    Muzykantov VR; Smirnov MD; Zaltzman AB; Samokhin GP
    Anal Biochem; 1993 Feb; 208(2):338-42. PubMed ID: 8452230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers.
    Kim JH; Li Y; Kim MS; Kang SW; Jeong JH; Lee DS
    Int J Pharm; 2012 May; 427(2):435-42. PubMed ID: 22342467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte survival time in Greyhounds as assessed by use of in vivo biotinylation.
    Garon CL; Cohn LA; Scott MA
    Am J Vet Res; 2010 Sep; 71(9):1033-8. PubMed ID: 20807142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tannin-mediated attachment of avidin to erythrocytes does not cause their lysis by complement].
    Muzykantov VR; Smirnov MD; Zal'tsman AB; Samokhin GP
    Biokhimiia; 1993 Jul; 58(7):1027-32. PubMed ID: 8364121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method to attach lectins to the surface of spermine alginate microcapsules based on the avidin biotin interaction.
    Sultzbaugh KJ; Speaker TJ
    J Microencapsul; 1996; 13(4):363-76. PubMed ID: 8808774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avidin attachment to biotinylated erythrocytes induces homologous lysis via the alternative pathway of complement.
    Muzykantov VR; Smirnov MD; Samokhin GP
    Blood; 1991 Nov; 78(10):2611-8. PubMed ID: 1824256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of NADPH-cytochrome P450 reductase antisense oligos using avidin-biotin approach.
    Pillai VC; Yesudas R; Shaik IH; Thekkumkara TJ; Bickel U; Srivenugopal KS; Mehvar R
    Bioconjug Chem; 2010 Feb; 21(2):203-7. PubMed ID: 20063878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.